Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tim Anderson is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/10/2025 | AARD | Buy Now | Aardvark Therapeutics | $9.09 | 142.02% | Tim Anderson47% | → $22 | Initiates | → Buy | Get Alert |
| 03/05/2025 | JNJ | Buy Now | Johnson & Johnson | $161.00 | 6.21% | Tim Anderson47% | $159 → $171 | Maintains | Neutral | Get Alert |
| 03/05/2025 | GILD | Buy Now | Gilead Sciences | $107.89 | 16.79% | Tim Anderson47% | $116 → $126 | Maintains | Buy | Get Alert |
| 03/05/2025 | AMGN | Buy Now | Amgen | $302.26 | -2.73% | Tim Anderson47% | $275 → $294 | Maintains | Underperform | Get Alert |
| 03/04/2025 | ABBV | Buy Now | AbbVie | $201.34 | 10.76% | Tim Anderson47% | $200 → $223 | Maintains | Neutral | Get Alert |
| 02/25/2025 | MTSR | Buy Now | Metsera | $29.16 | 30.32% | Tim Anderson47% | → $38 | Initiates | → Buy | Get Alert |
| 02/11/2025 | MRNA | Buy Now | Moderna | $33.95 | 0.15% | Tim Anderson47% | $41 → $34 | Maintains | Underperform | Get Alert |
| 02/06/2025 | AMGN | Buy Now | Amgen | $302.26 | -9.02% | Tim Anderson47% | $256 → $275 | Maintains | Underperform | Get Alert |
| 02/05/2025 | MRK | Buy Now | Merck & Co | $88.03 | 27.23% | Tim Anderson47% | $118 → $112 | Maintains | Buy | Get Alert |
| 01/23/2025 | JNJ | Buy Now | Johnson & Johnson | $161.00 | -1.24% | Tim Anderson47% | $160 → $159 | Maintains | Neutral | Get Alert |
| 01/17/2025 | JNJ | Buy Now | Johnson & Johnson | $161.00 | -0.62% | Tim Anderson47% | $166 → $160 | Maintains | Neutral | Get Alert |
| 12/10/2024 | PFE | Buy Now | Pfizer | $25.64 | 13.1% | Tim Anderson47% | → $29 | Reinstates | → Neutral | Get Alert |
| 12/10/2024 | JNJ | Buy Now | Johnson & Johnson | $161.00 | 3.1% | Tim Anderson47% | → $166 | Reinstates | → Neutral | Get Alert |
| 12/10/2024 | BMY | Buy Now | Bristol-Myers Squibb | $59.35 | 6.15% | Tim Anderson47% | → $63 | Reinstates | → Neutral | Get Alert |
| 12/10/2024 | BIIB | Buy Now | Biogen | $139.16 | 27.91% | Tim Anderson47% | → $178 | Reinstates | → Neutral | Get Alert |
| 12/10/2024 | ABBV | Buy Now | AbbVie | $201.34 | -5.14% | Tim Anderson47% | → $191 | Reinstates | → Neutral | Get Alert |
| 12/10/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $633.16 | -10.77% | Tim Anderson47% | → $565 | Reinstates | → Underperform | Get Alert |
| 12/10/2024 | MRNA | Buy Now | Moderna | $33.95 | 20.77% | Tim Anderson47% | → $41 | Reinstates | → Underperform | Get Alert |
| 12/10/2024 | AMGN | Buy Now | Amgen | $302.26 | -15.3% | Tim Anderson47% | → $256 | Reinstates | → Underperform | Get Alert |
| 12/10/2024 | MRK | Buy Now | Merck & Co | $88.03 | 37.45% | Tim Anderson47% | → $121 | Reinstates | → Buy | Get Alert |
| 12/10/2024 | GILD | Buy Now | Gilead Sciences | $107.89 | 1.03% | Tim Anderson47% | → $109 | Reinstates | → Buy | Get Alert |
| 12/10/2024 | LLY | Buy Now | Eli Lilly | $853.45 | 16.82% | Tim Anderson47% | → $997 | Reinstates | → Buy | Get Alert |
| 11/15/2024 | AMGN | Buy Now | Amgen | $302.26 | — | Tim Anderson47% | — | Initiates | → Peer Perform | Get Alert |
| 02/22/2023 | ABBV | Buy Now | AbbVie | $201.34 | — | Tim Anderson47% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 02/22/2023 | MRK | Buy Now | Merck & Co | $88.03 | 44.27% | Tim Anderson47% | → $127 | Upgrade | Peer Perform → Outperform | Get Alert |
| 05/09/2022 | NVS | Buy Now | Novartis | $113.40 | — | Tim Anderson47% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 05/01/2022 | ABBV | Buy Now | AbbVie | $201.34 | -15.57% | Tim Anderson47% | $172 → $170 | Maintains | Outperform | Get Alert |
| 05/03/2021 | ABBV | Buy Now | AbbVie | $201.34 | -36.92% | Tim Anderson47% | $125 → $127 | Maintains | Outperform | Get Alert |
| 06/12/2020 | MRK | Buy Now | Merck & Co | $88.03 | — | Tim Anderson47% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 09/22/2017 | AZN | Buy Now | AstraZeneca | $72.60 | — | Tim Anderson47% | — | Upgrade | Market Perform → Outperform | Get Alert |
